INFANTILE REFSUM DISEASE

INFANTILE REFSUM DISEASE

What Is Infantile Refsum Disease?

Infantile Refsum disease (IRD) is one of a small group of genetic diseases called peroxisome biogenesis disorders (PBD), which are part of a larger group of diseases called the leukodystrophies. These are inherited conditions that damage the white matter of the brain and affect motor movements. IRD is the mildest of the PBDs; Zellweger syndrome, neonatal adrenoleukodystrophy and rhizomelic chondrodysplasia have similar, but more severe, symptoms. The PBDs are caused by defects in the genes that are associated with the breakdown of phytanic acid, a substance commonly found in foods. As a result, toxic levels of phytanic acid build up in the brain, blood and other tissues. Symptoms of IRD begin in infancy with a visual impairment called retinitis pigmentosa, which often leads to blindness, and hearing problems that usually progress to deafness by early childhood. Other symptoms may include rapid, jerky eye movements (nystagmus); floppy muscle tone (hypotonia) and lack of muscle coordination (ataxia); mental and growth retardation; mild abnormalities in the form and structure of the face (dysmorphia); enlargement of the liver (hepatomegaly); and low cholesterol (hypocholesterolemia). Although Adult Refsum disease and IRD have similar names, they are separate disorders caused by different biomechanisms involved in the breakdown of phytanic acid.

Is There Any Treatment?

The primary treatment for IRD is to avoid foods that contain phytanic acid, including dairy products; beef and lamb; and fatty fish, such as tuna, cod and haddock. Some infants and children also may require plasma exchange (plasmapheresis) in which blood is drawn, filtered and reinfused back into the body, to control the buildup of phytanic acid.

What Is the Prognosis?

IRD is a fatal disease, but some children will survive into their teens and 20s and possibly even beyond.

What Research Is Being Done?

The National Institute of Neurological Disorders and Stroke, a part of the National Institutes of Health, conducts research related to IRD in its laboratories and also supports additional research through grants to major medical institutions across the country. Research is focused on finding better ways to prevent, treat and ultimately cure disorders such as the PBDs.

Автоматический перевод на русский язык


Читать другие статьи на эту тему